ImmunologybioRxivPreprint
LAT1 enables T cell activation under inflammatory conditions: a new therapeutic target for rheumatoid arthritis
J. Ogbechi, H. L. Wright, S. Balint…·R. Williams
This study shows LAT1 is critical for T cell activation in rheumatoid arthritis and identifies it as a therapeutic target, with a LAT1 inhibitor effective in mouse models.
DOI 10.1101/2022.12.20.520910